Mizuho comments on Select Medical (SEM) takeover; "we believe the $16.50 per share valuation is fair"
Tweet Send to a Friend
Mizuho analyst Ann Hynes reiterated an Outperform rating and $17.00 price target on Select Medical Holdings (NYSE: SEM)The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
